162 related articles for article (PubMed ID: 7527538)
1. Maternal serum free alpha-human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome.
Wald NJ; Densem JW
Prenat Diagn; 1994 Aug; 14(8):717-9. PubMed ID: 7527538
[TBL] [Abstract][Full Text] [Related]
2. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome.
Wald N; Cuckle H; Wu TS; George L
Br J Obstet Gynaecol; 1991 Sep; 98(9):905-8. PubMed ID: 1716981
[TBL] [Abstract][Full Text] [Related]
3. Maternal serum inhibin-A levels in twin pregnancies: implications for screening for Down's syndrome.
Watt HC; Wald NJ; George L
Prenat Diagn; 1996 Oct; 16(10):927-9. PubMed ID: 8938062
[TBL] [Abstract][Full Text] [Related]
4. Down's syndrome screening in multiple pregnancies using alpha-fetoprotein and free beta hCG.
Spencer K; Salonen R; Muller F
Prenat Diagn; 1994 Jul; 14(7):537-42. PubMed ID: 7526363
[TBL] [Abstract][Full Text] [Related]
5. Four-marker serum screening for Down's syndrome.
Wald NJ; Densem JW; Smith D; Klee GG
Prenat Diagn; 1994 Aug; 14(8):707-16. PubMed ID: 7527537
[TBL] [Abstract][Full Text] [Related]
6. Maternal serum free alpha- and free beta-human chorionic gonadotrophin in pregnancies with insulin-dependent diabetes mellitus: implications for screening for Down's syndrome.
Wald NJ; Densem JW; Cheng R; Collishaw S
Prenat Diagn; 1994 Sep; 14(9):835-7. PubMed ID: 7531328
[TBL] [Abstract][Full Text] [Related]
7. Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening.
Berry E; Aitken DA; Crossley JA; Macri JN; Connor JM
Prenat Diagn; 1995 Jun; 15(6):555-65. PubMed ID: 7544898
[TBL] [Abstract][Full Text] [Related]
8. The use of free beta-hCG in antenatal screening for Down's syndrome.
Wald N; Densem J; Stone R; Cheng R
Br J Obstet Gynaecol; 1993 Jun; 100(6):550-7. PubMed ID: 7687460
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: implications for screening for Down's syndrome.
Wald NJ; Cuckle HS; Densem JW; Stone RB
Br J Obstet Gynaecol; 1992 Jan; 99(1):51-3. PubMed ID: 1372176
[TBL] [Abstract][Full Text] [Related]
10. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
Wald NJ; Watt HC
Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
[TBL] [Abstract][Full Text] [Related]
11. Effect of allowing for ethnic group in prenatal screening for Down's syndrome.
Watt HC; Wald NJ; Smith D; Kennard A; Densem J
Prenat Diagn; 1996 Aug; 16(8):691-8. PubMed ID: 8878277
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum free beta-human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome.
Wald NJ; Densem JW
Prenat Diagn; 1994 Apr; 14(4):319-20. PubMed ID: 8066044
[TBL] [Abstract][Full Text] [Related]
13. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol.
Extermann P; Bischof P; Marguerat P; Mermillod B
Hum Reprod; 1998 Jan; 13(1):220-3. PubMed ID: 9512261
[TBL] [Abstract][Full Text] [Related]
14. Screening of maternal serum for fetal Down's syndrome in the first trimester.
Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A
N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983
[TBL] [Abstract][Full Text] [Related]
15. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group.
Wald NJ; George L; Smith D; Densem JW; Petterson K
Br J Obstet Gynaecol; 1996 May; 103(5):407-12. PubMed ID: 8624312
[TBL] [Abstract][Full Text] [Related]
16. The influence of gravidity on Down's syndrome screening with free beta hCG.
Spencer K
Prenat Diagn; 1995 Jan; 15(1):87-9. PubMed ID: 7537879
[TBL] [Abstract][Full Text] [Related]
17. Maternal serum inhibin-A in pregnancies with insulin-dependent diabetes mellitus: implications for screening for Down's syndrome.
Wald NJ; Watt HC; George L
Prenat Diagn; 1996 Oct; 16(10):923-6. PubMed ID: 8938061
[TBL] [Abstract][Full Text] [Related]
18. SURUSS in perspective.
Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
[TBL] [Abstract][Full Text] [Related]
19. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
Muller F; Dreux S; Dupoizat H; Uzan S; Dubin MF; Oury JF; Dingeon B; Dommergues M
Prenat Diagn; 2003 Apr; 23(4):331-5. PubMed ID: 12673641
[TBL] [Abstract][Full Text] [Related]
20. Enhanced twin pregnancy detection within an open neural tube defect and Down syndrome screening protocol using free-beta hCG and AFP.
Barnabei VM; Krantz DA; Macri JN; Larsen JW
Prenat Diagn; 1995 Dec; 15(12):1131-4. PubMed ID: 8750293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
